Target intelligence / Profile preview

Solute carrier family 39 member 4 (SLC39A4) (SLC39A4)

Target
SLC39A4
Molecular classification
Transporter, SLC39A family, ZIP family
01

Overview

Solute carrier family 39 member 4 (SLC39A4), also known as ZIP4, is the primary protein responsible for the apical uptake of dietary zinc within the intestinal epithelium (Wang et al., 2002). It belongs to the ZIP family of metal transporters, which are essential for maintaining cellular zinc homeostasis by moving zinc from the extracellular environment or intracellular organelles into the cytosol (UniProt P58143). Mutations in the SLC39A4 gene are the underlying cause of acrodermatitis enteropathica, a severe genetic disorder characterized by impaired zinc absorption, dermatitis, alopecia, and diarrhea (Kury et al., 2002). Beyond its physiological role in nutrition, SLC39A4 is frequently overexpressed in several aggressive malignancies, including pancreatic and liver cancers, where it promotes tumor growth, epithelial-mesenchymal transition, and metastasis (Li et al., 2007; Liu et al., 2011). Consequently, while it is a target for nutritional intervention via zinc supplementation, it is also being investigated as a potential therapeutic target for cancer inhibition. The term Zinc uptake systems in intestinal epithelium is a functional description of the physiological process primarily mediated by this specific molecular transporter.

Other names
ZIP4Zrt- and Irt-like protein 4Acrodermatitis enteropathica zinc transporterZinc transporter ZIP4Zinc uptake systems in intestinal epithelium
02

Mechanism of action

SLC39A4 functions as a transmembrane transporter that facilitates the influx of divalent zinc ions (Zn2+) from the intestinal lumen across the apical membrane into the cytoplasm of enterocytes (Geiser et al., 2012). In the context of therapeutic supplementation, high doses of oral zinc salts utilize this and alternative pathways to restore systemic zinc levels in deficiency states (Kury et al., 2002).

03

Biological functions

Zinc ion transportMetal ion homeostasisIntestinal absorptionCell proliferationApoptosis regulation
04

Disease associations

Acrodermatitis enteropathicaZinc deficiencyPancreatic cancerHepatocellular carcinomaEsophageal squamous cell carcinoma
05

Safety considerations

Secondary copper deficiency (due to induction of metallothionein)Gastrointestinal irritationZinc toxicity (acute and chronic)Genotoxicity at extremely high concentrations
06

Interacting drugs

Zinc gluconate

4 more in the full profile.

07

Biomarkers

Serum zinc concentrationPlasma alkaline phosphatase activitySLC39A4 mRNA expression (in tumor tissue)Urinary zinc excretion

Beyond the preview

Go deeper on Solute carrier family 39 member 4 (SLC39A4) (SLC39A4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 39 member 4 (SLC39A4) (SLC39A4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call